Detalles de la búsqueda
1.
Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270043
2.
Neutralizing antibodies elicited by the Ad26.COV2.S COVID-19 vaccine show reduced activity against 501Y.V2 (B.1.351), despite protection against severe disease by this variant.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-447722
3.
Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21262569
4.
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259918
5.
Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concern
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-450707
6.
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22272763
Resultados
1 -
6
de 6
1
Próxima >
>>